|
|
Volumn 35, Issue 3, 2001, Pages 285-288
|
|
Comparison of FDA reports of patient deaths associated with sildenafil and with injectable alprostadil
a
a
Box 120
*
(United States)
|
|
Author keywords
Erectile dysfunction; Sildenafil
|
|
Indexed keywords
PROSTAGLANDIN E1;
SILDENAFIL;
ARTICLE;
CAUSE OF DEATH;
CLINICAL TRIAL;
DISEASE ASSOCIATION;
DRUG FATALITY;
DRUG SAFETY;
ERECTILE DYSFUNCTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
POSTMARKETING SURVEILLANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
|
|
EID: 0035090758
PISSN: 10600280
EISSN: None
Source Type: Journal
DOI: 10.1345/aph.10218 Document Type: Article |
|
Times cited : (18)
|
|
References (10)
|
